Plus   Neg

General Mills Raises Q4, FY20 Outlook - Quick Facts

General Mills (GIS) has raised its financial expectations for the fourth quarter of fiscal 2020 to reflect stronger than anticipated at-home food demand in March and April, with an expectation that trends will moderate in May but remain significantly ahead of pre-COVID-19 levels.

The company expects fourth-quarter organic net sales to increase double digits versus the prior year, led by strong growth in North America Retail and Pet.

It projects fourth-quarter constant-currency adjusted operating profit to grow faster than organic net sales, reflecting benefits from operating leverage, partially offset by increased costs related to COVID-19.

The company now expects to exceed each of its previous full-year fiscal 2020 guidance ranges of 1 to 2 percent organic net sales growth, 4 to 6 percent growth in constant-currency adjusted operating profit, and 6 to 8 percent growth in constant-currency adjusted earnings per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Moderna said Tuesday that it has reached an agreement with the U.S. to initially supply 100 million doses of its experimental vaccine for COVID-19, mRNA-1273. The U.S. government has awarded up to $1.525 billion for the vaccine. Las Vegas, Nevada-based Mr. Wok Foods has recalled about 200,000 pounds of meat and poultry products for misbranding and undeclared allergens, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The recalled products may contain known allergens such as milk, wheat, soy, peanuts, or oysters. They may also contain MSG, sesame products, or sulfites. The U.S. Food and Drug Administration approved the first oral drug to treat patients two months of age and older with spinal muscular atrophy (SMA) that can be taken at home. Roche subsidiary Genentech's Evrysdi (risdiplam) is also the second FDA-approved drug to treat this rare and often fatal genetic disease affecting muscle strength and movement.
Follow RTT